Cost & Insurance

What GLP-1 treatment actually costs, plus how insurance, Medicare, and savings cards change the price.

6 articles in this category.

Start here

Choose the question you want to answer first.

Looking for your state? Browse state coverage guides
A cream folder, itemized receipts, an unbranded green payment card and a pen on a pale stone desk.
GuideCost & Insurance

Can You Use HSA or FSA Funds for GLP-1 Medication?

GLP-1 treatment may qualify for HSA or FSA payment, but a card logo is not approval of every charge. Check the prescription, invoice, account rules and timing before paying.

October 5, 2026

6 min read

Unbranded vial on a folded blank statement with green glass behind it, a conceptual illustration of treatment costs.
AnalysisCost & Insurance

GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)

Without insurance, brand GLP-1s cost $149 to $499 a month direct from the makers: Foundayo and the Wegovy pill from $149, Zepbound from $299, and the Wegovy pen $199 for the first two low-dose fills, then $349. If your commercial plan covers the drug, a savings card can bring it to $25. On Medicare, the GLP-1 Bridge charges $50 a month if you qualify.

July 6, 2026

11 min read

Reading glasses, a blank blue card and an amber bottle beside paperwork on a wooden desk.
GuideCost & Insurance

Does Medicare Cover Wegovy, Zepbound or Ozempic for Weight Loss in 2026?

Yes for Wegovy and the Zepbound KwikPen, if you qualify: the Medicare GLP-1 Bridge covers them for weight management at $50 a month. Ozempic is not in the Bridge, and basic Part D does not pay for it solely for weight loss. Check the exact drug, form and reason it is prescribed before you pay.

July 6, 2026

8 min read

Editorial still-life evoking metabolic balance and women's health, warm natural light
GuideCost & Insurance

Ozempic for PCOS (2026): Evidence, Coverage and Cost

Ozempic is not FDA-approved for PCOS. It is approved for type 2 diabetes. The 2023 international PCOS guideline says semaglutide may be considered, alongside active lifestyle intervention, for weight management in adults with PCOS and higher weight under general-population criteria. That is different from an approval to treat PCOS or infertility. Coverage depends on the prescribed product, approved indication, plan formulary and prior-authorization rules. This guide separates the evidence from the labels, then compares realistic coverage and cash-pay paths.

June 24, 2026

11 min read

Editorial photograph illustrating the FDA compounded semaglutide enforcement crackdown
NewsCost & Insurance

Compounded Semaglutide After the Shortage: FDA Enforcement and Switch Options

FDA resolved the semaglutide shortage on February 21, 2025. Temporary shortage-based enforcement discretion ended after an April 24 court decision for 503A pharmacies and on May 22 for 503B facilities. This guide separates those dates from FDA's pending 503B bulk-list proposal and compares paths to discuss with a prescriber.

June 19, 2026

13 min read

Editorial photograph illustrating compounded tirzepatide and legal considerations
AnalysisCost & Insurance

Is Compounded Tirzepatide Legal and Safe? FDA Rules and What Changed in 2026

It depends on the pharmacy and the prescription. Tirzepatide's shortage ended in October 2024, the broad shortage pathway for compounding closed in early 2025, and FDA has not reviewed compounded tirzepatide for safety or quality. Programs still sell it. Here is what each charges, what the law requires and what to check before you pay.

April 11, 2026

13 min read

Ready to pick a provider? Take the 60-second match quiz or browse our full GLP-1 provider rankings.

Featured Partners

Affiliate partners we feature. We may earn a commission.

Embody

Embody illustration of a compounded semaglutide injection vial
from $49/mo·Compounded

Collective

Collective provider illustration of compounded semaglutide injection vial
from $59/mo + $199/year membership after 21 days·Compounded

Gala

Current program options·Brand & Compounded

Check the medication, commitment and total price for your selected plan.

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.